デフォルト表紙
市場調査レポート
商品コード
1478651

腸骨ステント市場、シェア、市場規模、動向、産業分析レポート:タイプ別、動脈病変別、最終用途別、地域別、セグメント別予測、2024年~2032年

Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End Use, By Region, And Segment Forecasts, 2024 - 2032


出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
腸骨ステント市場、シェア、市場規模、動向、産業分析レポート:タイプ別、動脈病変別、最終用途別、地域別、セグメント別予測、2024年~2032年
出版日: 2024年04月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示

  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、腸骨ステントの世界市場規模は2032年までに17億854万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

腸骨動脈病変や動脈瘤の治療のための腸骨ステント手術では、いくつかのステントが使用されます。研究によると、腸骨動脈病変の管理に関しては、EPICステントなどのステントが他よりも優れた臨床結果を示しています。自己拡張型EPICステントは、その柔軟性、治癒の改善、新生内膜過形成の減少により、腸骨動脈処置の有望な選択肢です。

米国心臓協会(AHA)が発表したデータによると、米国では約850万人の成人が末梢動脈疾患(PAD)を患っています。PADは腸骨動脈を閉塞させるので、より円滑な心臓機能のためには腸骨ステント留置が必要です。

さらに、腸骨動脈瘤の治療には、開腹手術によるグラフト挿入に代わる経皮的ステントグラフト移植術が用いられます。腸骨動脈瘤の治療には、この低侵襲治療でステントグラフトが移植され、従来の外科的再建よりも侵襲の少ない方法が提供されます。

総腸骨動脈では、DISCOVERの調査によって、被覆型と非被覆型のバルーン拡張型ステントの違いが明らかにされ、PTFEで被覆されたステントが再狭窄率を低下させ、血管内治療後の臨床転帰を改善する可能性が強調されました。腸骨動脈全閉塞に対するバルーン血管形成術を上回る一次ステント植え込み術の利点をさらに裏付けるものとして、STAG試験の結果があり、ステント植え込み術は技術的成功率が高く、重大な手技的問題の発生率が低いことを示しています。

例えば、2022年5月には、下肢の動脈症患者における大動脈-腸骨アテローム硬化病変の治療に対するiCoverの安全性と有効性を評価するために、iVascularが監修したiliCo試験が、この薬剤を用いた最初の試験を開始しました。

腸骨ステント市場レポートハイライト

自己拡張型ステントが腸骨動脈閉塞症によく使用されることがさまざまな研究で実証されたため、自己拡張型ステントが市場を席巻。

バルーン拡張型ステントは、橈骨外側に強い力をかけることができ、ステントを正確に留置することができるため、最も速い速度で成長すると予想されます。

完全閉塞性病変セグメントは、PADの罹患率の上昇、医学の進歩、心血管疾患により、最も速い速度で成長すると予想されます。

北米は、PADの発生率の上昇、高齢者人口の増加、糖尿病や肥満などの危険因子の増加により、腸骨ステント市場を独占しています。

主な市場プレイヤーは、Abbott、BD、Biotronik SE &Co KG、Boston Scientific Corporation、Cook、Getinge AB、iVascular、Medtronic、Terumo Corporationなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の腸骨ステント市場の洞察

  • 最終用途スナップショット
  • 腸骨ステント市場力学
    • 促進要因と機会
      • 腸骨ステント設計における技術的進歩
      • 末梢動脈疾患(PAD)の罹患率の増加
    • 抑制要因と課題
      • 認識不足と診断不足
  • PESTEL分析
  • 腸骨ステント市場の最終用途の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の腸骨ステント市場:タイプ別

  • 主な調査結果
  • イントロダクション
  • 自己拡張型ステント
  • バルーン拡張型ステント
  • その他

第6章 世界の腸骨ステント市場:動脈病変別

  • 主な調査結果
  • イントロダクション
  • 総腸骨動脈病変
  • 重度の石灰化病変
  • 完全閉塞性病変

第7章 世界の腸骨ステント市場:最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来手術センター
  • その他

第8章 世界の腸骨ステント市場:地域

  • 主な調査結果
  • イントロダクション
    • 腸骨ステント市場評価:地域別、2019-2032年
  • 北米
    • 北米:タイプ別、2019-2032年
    • 北米:最終用途別、2019年~2032年
    • 北米:動脈病変別、2019年~2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州:タイプ別、2019-2032
    • 欧州:最終用途別、2019-2032年
    • 欧州:動脈病変別、2019-2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域:タイプ別、2019-2032
    • アジア太平洋地域:最終用途別、2019年~2032年
    • アジア太平洋地域:動脈病変別、2019-2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ:タイプ別、2019年~2032年
    • 中東・アフリカ:最終用途別、2019-2032年
    • 中東・アフリカ:動脈病変別、2019-2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ:タイプ別、2019-2032年
    • ラテンアメリカ:最終用途別、2019-2032年
    • ラテンアメリカ:動脈病変別、2019年~2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott
  • BD
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cook
  • Getinge AB
  • iVascular
  • Medtronic
  • Terumo Corporation
  • W. L. Gore & Associates, Inc
図表

List of Tables

  • Table 1 Global Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 3 Global Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 4 Iliac Stent Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 6 North America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 7 North America: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 8 U.S.: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 10 U.S.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 11 Canada: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 12 Canada: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 13 Canada: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 14 Europe: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 15 Europe: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 16 Europe: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 17 UK: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 18 UK: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 19 UK: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 20 France: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 21 France: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 22 France: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 23 Germany: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 24 Germany: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 25 Germany: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 26 Italy: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 27 Italy: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 28 Italy: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 29 Spain: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 30 Spain: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 31 Spain: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 32 Netherlands: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 34 Netherlands: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 35 Russia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 36 Russia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 37 Russia: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 41 China: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 42 China: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 43 China: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 44 India: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 45 India: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 46 India: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 47 Malaysia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 49 Malaysia: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 50 Japan: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 51 Japan: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 52 Japan: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 53 Indonesia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 55 Indonesia: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 56 South Korea: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 58 South Korea: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 65 UAE: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 66 UAE: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 67 UAE: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 68 Israel: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 69 Israel: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 70 Israel: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 71 South Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 73 South Africa: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 74 Latin America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 76 Latin America: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 77 Mexico: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 79 Mexico: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 80 Brazil: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 82 Brazil: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • Table 83 Argentina: Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • Table 85 Argentina: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Iliac Stent Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Artery Lesions
  • Figure 7. Global Iliac Stent Market, by Artery Lesions, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Iliac Stent Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global Iliac Stent Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 12. Iliac Stent Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Iliac Stent Market
目次
Product Code: PM4857

The global Iliac stent market size is expected to reach USD 1,708.54 Million by 2032, according to a new study by Polaris Market Research. The report "Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End-use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Several stents are used during iliac stent surgeries for the treatment of iliac arterial lesions and aneurysms. According to studies, stents such as the EPIC stent have shown superior clinical outcomes than others when it comes to managing iliac arterial lesions. The self-expanding EPIC stent is a promising alternative for iliac artery procedures due to its flexibility, improved healing, and decreased neointimal hyperplasia.

As per the data published by the American Heart Association (AHA), around 8.5 Mn adults in the U.S. are suffering from Peripheral Arterial Disease (PAD). PAD blocks iliac arteries; therefore, iliac stenting is required for smoother heart functioning.

In addition, iliac artery aneurysms are treated using percutaneous stent-graft implantation, which offers a replacement for open surgery graft insertion. Stent grafts are implanted during this minimally invasive treatment to treat iliac aneurysms, providing a less invasive method than conventional surgical reconstruction.

In the common iliac artery, the DISCOVER research has clarified the differences among covered and uncovered balloon-expandable stents, highlighting the potential of PTFE-covered stents to lower restenosis rates and enhance clinical outcomes following endovascular therapy. Further supporting the benefits of primary stent implantation above balloon angioplasty for full iliac artery occlusions are the results of the STAG study, which show that stent intervention is associated with a higher rate of technical success and a lower rate of significant procedural problems.

For instance, in May 2022, to assess the safety & effectiveness of iCover for treating aorto-iliac athero-sclerotic lesions in patients with the arteriopathy in the lower limbs, the iliCo study, supervised by iVascular, started its first trial with the drug.

Iliac Stent Market Report Highlights

Self-expandable stents segment dominated the market owing to various studies demonstrated self-expanding stents are commonly used for iliac artery occlusions.

Balloon-expandable stents segment expected to grow at the fastest rate, due to its capabilities such as severe radial outward force, and ability to accurately place stents.

Complete obstructive lesion segment expected to grow at the fastest rate due to rising the incidence of PAD, advancements in medicine, and cardiovascular diseases.

North America dominated the iliac stents market due to the rising incidence of PAD and rising older population and increasing risk factors such as diabetic and obesity

The key market players include Abbott, BD, Biotronik SE & Co KG, Boston Scientific Corporation, Cook, Getinge AB, iVascular, Medtronic, and Terumo Corporation.

Polaris Market Research has segmented the Iliac Stent market report based on type, artery lesions, end use, and region:

Iliac Stent, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Self-expandable Stents
  • Balloon-expandable Stents
  • Others

Iliac Stent, Artery Lesions Outlook (Revenue - USD Million, 2019 - 2032)

  • Common Iliac Artery Lesions
  • Severe Calcified Lesions
  • Complete Obstructive Lesions

Iliac Stent, End Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Ambulatory surgical centers
  • Others

Iliac Stent, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Iliac Stent Market Insights

  • 4.1. Iliac Stent Market - End-Use Snapshot
  • 4.2. Iliac Stent Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Technological advancements in iliac stent designs
      • 4.2.1.2. Increasing prevalence of peripheral artery disease (PAD)
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited awareness and underdiagnosis
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Iliac Stent Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Iliac Stent Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Iliac Stent Market, by Type, 2019-2032 (USD Million)
  • 5.3. Self-expandable Stents
    • 5.3.1. Global Iliac Stent Market, by Self-expandable Stents, by Region, 2019-2032 (USD Million)
  • 5.4. Balloon-expandable Stents
    • 5.4.1. Global Iliac Stent Market, by Balloon-expandable Stents, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Iliac Stent Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Iliac Stent Market, by Artery Lesions

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • 6.3. Common Iliac Artery Lesions
    • 6.3.1. Global Iliac Stent Market, by Common Iliac Artery Lesions, by Region, 2019-2032 (USD Million)
  • 6.4. Severe Calcified Lesions
    • 6.4.1. Global Iliac Stent Market, by Severe Calcified Lesions, by Region, 2019-2032 (USD Million)
  • 6.5. Complete Obstructive Lesions
    • 6.5.1. Global Iliac Stent Market, by Complete Obstructive Lesions, by Region, 2019-2032 (USD Million)

7. Global Iliac Stent Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Iliac Stent Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.4. Ambulatory surgical centers
    • 7.4.1. Global Iliac Stent Market, by Ambulatory surgical centers, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Iliac Stent Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Iliac Stent Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Iliac Stent Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Iliac Stent Market - North America
    • 8.3.1. North America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.3. North America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.3.4. Iliac Stent Market - U.S.
      • 8.3.4.1. U.S.: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.3.5. Iliac Stent Market - Canada
      • 8.3.5.1. Canada: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • 8.4. Iliac Stent Market - Europe
    • 8.4.1. Europe: Iliac Stent Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.3. Europe: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.4.4. Iliac Stent Market - UK
      • 8.4.4.1. UK: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.4.5. Iliac Stent Market - France
      • 8.4.5.1. France: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.5.3. France: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.4.6. Iliac Stent Market - Germany
      • 8.4.6.1. Germany: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.4.7. Iliac Stent Market - Italy
      • 8.4.7.1. Italy: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.4.8. Iliac Stent Market - Spain
      • 8.4.8.1. Spain: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.4.9. Iliac Stent Market - Netherlands
      • 8.4.9.1. Netherlands: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.4.10. Iliac Stent Market - Russia
      • 8.4.10.1. Russia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • 8.5. Iliac Stent Market - Asia Pacific
    • 8.5.1. Asia Pacific: Iliac Stent Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.5.4. Iliac Stent Market - China
      • 8.5.4.1. China: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.4.3. China: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.5.5. Iliac Stent Market - India
      • 8.5.5.1. India: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.5.3. India: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.5.6. Iliac Stent Market - Malaysia
      • 8.5.6.1. Malaysia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.5.7. Iliac Stent Market - Japan
      • 8.5.7.1. Japan: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.5.8. Iliac Stent Market - Indonesia
      • 8.5.8.1. Indonesia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.5.9. Iliac Stent Market - South Korea
      • 8.5.9.1. South Korea: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • 8.6. Iliac Stent Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.6.4. Iliac Stent Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.6.5. Iliac Stent Market - UAE
      • 8.6.5.1. UAE: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.6.6. Iliac Stent Market - Israel
      • 8.6.6.1. Israel: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.6.7. Iliac Stent Market - South Africa
      • 8.6.7.1. South Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
  • 8.7. Iliac Stent Market - Latin America
    • 8.7.1. Latin America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.7.4. Iliac Stent Market - Mexico
      • 8.7.4.1. Mexico: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.7.5. Iliac Stent Market - Brazil
      • 8.7.5.1. Brazil: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
    • 8.7.6. Iliac Stent Market - Argentina
      • 8.7.6.1. Argentina: Iliac Stent Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BD
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biotronik SE & Co KG
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Boston Scientific Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Cook
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Getinge AB
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. iVascular
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medtronic
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Terumo Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. W. L. Gore & Associates, Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development